Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.20 Insider Own40.01% Shs Outstand24.20M Perf Week-0.61%
Market Cap39.45M Forward P/E- EPS next Y-0.34 Insider Trans0.00% Shs Float14.52M Perf Month19.85%
Income-29.13M PEG- EPS next Q-0.24 Inst Own49.49% Short Float / Ratio0.23% / 0.13 Perf Quarter-16.84%
Sales79.73M P/S0.49 EPS this Y57.80% Inst Trans- Short Interest0.03M Perf Half Y-58.65%
Book/sh-1.72 P/B- EPS next Y60.19% ROA-38.19% Target Price6.46 Perf Year-68.41%
Cash/sh0.95 P/C1.72 EPS next 5Y- ROE- 52W Range0.88 - 4.96 Perf YTD-53.84%
Dividend- P/FCF- EPS past 5Y-20.91% ROI- 52W High-67.14% Beta1.32
Dividend %- Quick Ratio0.35 Sales past 5Y16.06% Gross Margin69.70% 52W Low85.23% ATR0.17
Employees144 Current Ratio0.42 Sales Q/Q0.21% Oper. Margin-23.57% RSI (14)55.81 Volatility8.32% 11.21%
OptionableYes Debt/Eq- EPS Q/Q90.30% Profit Margin-36.54% Rel Volume0.00 Prev Close1.63
ShortableYes LT Debt/Eq- EarningsSep 26 BMO Payout- Avg Volume263.33K Price1.63
Recom1.40 SMA2013.60% SMA507.14% SMA200-38.61% Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Nov-17-22Initiated Cantor Fitzgerald Overweight $9
Jul-29-21Downgrade Canaccord Genuity Buy → Hold $8 → $3
Nov-24-23 07:30AM
Oct-31-23 12:34PM
Oct-26-23 09:11AM
Oct-25-23 04:13PM
07:00AM Loading…
Oct-24-23 07:00AM
Oct-19-23 07:30AM
Oct-16-23 07:30AM
Oct-13-23 07:30AM
Oct-12-23 07:30AM
Oct-04-23 07:30AM
Sep-26-23 07:47AM
Sep-25-23 07:30AM
07:00AM Loading…
Sep-20-23 07:00AM
Sep-18-23 04:15PM
Sep-07-23 01:57PM
Sep-05-23 07:00AM
Aug-30-23 10:34AM
Aug-21-23 03:24PM
Aug-05-23 03:30PM
Jul-31-23 07:00AM
Jul-28-23 04:44PM
Jul-21-23 07:00AM
Jul-20-23 07:00AM
Jul-19-23 08:54AM
Jul-12-23 08:13AM
07:30AM Loading…
Jun-29-23 07:30AM
Jun-22-23 07:30AM
Jun-12-23 07:30AM
Jun-02-23 12:15PM
May-25-23 05:31PM
May-19-23 05:11PM
May-09-23 12:01PM
May-04-23 07:30AM
Apr-18-23 03:43PM
Apr-12-23 08:36AM
Apr-03-23 07:30AM
Mar-14-23 06:42PM
Mar-07-23 06:00AM
Mar-02-23 05:14AM
Feb-28-23 07:30AM
Feb-22-23 05:30PM
Feb-16-23 07:30AM
Feb-14-23 05:00PM
Jan-04-23 07:45AM
Dec-23-22 10:10AM
Dec-01-22 06:30PM
Nov-17-22 02:09PM
Oct-26-22 07:30AM
Oct-18-22 09:03AM
Oct-13-22 07:30AM
Oct-12-22 07:30AM
Oct-03-22 03:09PM
Sep-26-22 07:30AM
Sep-19-22 04:15PM
Sep-12-22 07:30AM
Aug-02-22 07:30AM
Jul-28-22 11:19AM
Jul-27-22 06:47PM
Jul-16-22 10:33AM
Jul-14-22 12:10PM
Jul-13-22 07:40AM
Jul-12-22 07:30AM
Jul-07-22 07:30AM
May-31-22 07:32AM
May-10-22 10:48AM
Apr-29-22 01:24PM
Apr-27-22 07:30AM
Apr-25-22 04:16PM
Apr-13-22 07:30AM
Apr-08-22 01:00PM
Mar-31-22 05:05PM
Mar-08-22 04:31PM
Feb-24-22 07:30AM
Feb-16-22 07:30AM
Feb-15-22 07:30AM
Feb-10-22 07:00AM
Jan-26-22 11:46AM
Dec-06-21 11:52AM
Nov-26-21 01:06PM
Nov-23-21 09:46AM
Nov-03-21 07:30AM
Oct-26-21 02:00AM
Oct-22-21 09:15AM
Oct-13-21 07:00AM
Oct-06-21 08:30AM
Sep-29-21 08:30AM
Sep-22-21 08:08AM
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montreal, Canada.